GOSSAMER BIO INC (GOSS) Stock Earnings & Estimates
NASDAQ:GOSS - US38341P1021 - Common Stock
3.11 USD
+0.34 (+12.27%)
3.12 USD
+0.01 (+0.32%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 114.701M | 36.351M -68.31% | 47.494M 30.65% | 119.64M 151.91% | 237.25M 98.30% | 392.41M 65.40% | 705.82M 79.87% | 726.2M 2.89% | 901.23M 24.10% | |||
| EBITDA YoY % growth | -216.69M -1.12% | -169.374M 21.84% | -55.768M 67.07% | -146.334M -162.40% | -43.62M 70.19% | 26.853M 161.56% | 67.932M 152.98% | 156.77M 130.77% | 296.92M 89.40% | N/A | N/A | |
| EBIT YoY % growth | -218.52M -1.15% | -173.759M 20.48% | -59.919M 65.52% | -160.963M -168.63% | -130.52M 18.91% | -53.663M 58.89% | 28.631M 153.35% | 139.29M 386.50% | 393.6M 182.58% | 348.15M -11.55% | 472.44M 35.70% | |
| Operating Margin | N/A | N/A | -52.24% | -442.80% | -274.81% | -44.85% | 12.07% | 35.50% | 55.76% | 47.94% | 52.42% | |
| EPS YoY % growth | -2.74 12.18% | -1.39 49.27% | -0.26 81.29% | -0.68 -160.84% | -0.50 26.85% | -0.27 45.52% | 0.08 129.25% | 0.32 303.23% | 0.47 48.80% | 0.76 60.75% | 1.01 33.11% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.19 -37.88% | -0.16 -8.80% | -0.17 -8.38% | -0.16 5.65% | -0.16 17.83% | -0.14 15.78% |
| Revenue Q2Q % growth | 5.902M -37.74% | 8.987M -4.18% | 5.534M -44.04% | 5.534M -51.83% | 3.4M -42.39% | 3.4M -62.17% |
| EBITDA Q2Q % growth | -35.394M -14.76% | -6.732M 78.95% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -43.455M -28.11% | -40.347M -11.68% | -49.913M -35.60% | -49.186M -26.88% | -50.772M -16.84% | -52.886M -31.08% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.17 -177.27% | -0.18 | 0.01 | 7.97% |
| Q1 2025 Q2Q % growth | -0.16 15.79% | -0.19 | 0.03 | 16.34% |
| Q4 2024 Q2Q % growth | -0.15 28.57% | -0.17 | 0.02 | 13.49% |
| Q3 2024 Q2Q % growth | -0.14 33.33% | -0.15 | 0.01 | 7.13% |
| Q2 2024 Q2Q % growth | 0.22 148.89% | 0.23 | -0.01 | -5.81% |
| Q1 2024 Q2Q % growth | -0.19 63.46% | -0.19 | 0.00 | 1.50% |
| Q4 2023 Q2Q % growth | -0.21 64.41% | -0.21 | 0.00 | 0.96% |
| Q3 2023 Q2Q % growth | -0.21 67.69% | -0.26 | 0.05 | 19.45% |
| Q2 2023 Q2Q % growth | -0.45 39.19% | -0.50 | 0.05 | 9.78% |
| Q1 2023 Q2Q % growth | -0.52 31.58% | -0.54 | 0.02 | 3.74% |
| Q4 2022 Q2Q % growth | -0.59 20.27% | -0.64 | 0.05 | 7.17% |
| Q3 2022 Q2Q % growth | -0.65 18.75% | -0.65 | 0.00 | -0.34% |
| Q2 2022 Q2Q % growth | -0.74 7.50% | -0.71 | -0.03 | -3.72% |
| Q1 2022 Q2Q % growth | -0.76 2.56% | -0.78 | 0.02 | 2.81% |
| Q4 2021 Q2Q % growth | -0.74 15.91% | -0.76 | 0.02 | 2.40% |
| Q3 2021 Q2Q % growth | -0.80 | -0.80 | 0.00 | 0.09% |
| Q2 2021 Q2Q % growth | -0.80 20.00% | -0.77 | -0.03 | -3.54% |
| Q1 2021 Q2Q % growth | -0.78 10.34% | -0.77 | -0.01 | -1.62% |
| Q4 2020 Q2Q % growth | -0.88 1.12% | -0.81 | -0.07 | -9.21% |
| Q3 2020 Q2Q % growth | -0.80 | -0.87 | 0.07 | 8.09% |
| Q2 2020 Q2Q % growth | -1.00 -35.14% | -0.88 | -0.12 | -13.56% |
| Q1 2020 Q2Q % growth | -0.87 3.33% | -0.82 | -0.05 | -6.62% |
| Q4 2019 Q2Q % growth | -0.89 | -0.88 | -0.01 | -1.46% |
| Q3 2019 Q2Q % growth | -0.80 | -0.71 | -0.09 | -12.85% |
| Q2 2019 Q2Q % growth | -0.74 | -0.57 | -0.17 | -29.55% |
| Q1 2019 Q2Q % growth | -0.90 | -0.67 | -0.23 | -34.71% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 11.489M -88.01% | 4.426M | 7.063M | 159.58% |
| Q1 2025 Q2Q % growth | 9.889M | 4.149M | 5.74M | 138.35% |
| Q4 2024 Q2Q % growth | 9.379M | 6.971M | 2.408M | 34.54% |
| Q3 2024 Q2Q % growth | 9.48M | 7.854M | 1.626M | 20.70% |
| Q2 2024 Q2Q % growth | 95.842M | 116.57M | -20.728M | -17.78% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -5.14% | 2.53% | 1.86% | 0.1% |
| Revenue | 4.17% | 62.54% | 21.67% | 24.51% |